GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Publication Date: 2023-02-08
    Description: Submarine groundwater discharge (SGD) into coastal areas is a common global phenomenon and is rapidly gaining scientific interest due to its influence on marine ecology, the coastal sedimentary environment and its potential as a future freshwater resource. We conducted an integrated study of hydroacoustic surveys combined with geochemical porewater and water column investigations at a well‐known groundwater seep site in Eckernförde Bay (Germany). We aim to better constrain the effects of shallow gas and SGD on high frequency multibeam backscatter data and to present acoustic indications for submarine groundwater discharge. Our high‐quality hydroacoustic data reveal hitherto unknown internal structures within the pockmarks in Eckernförde Bay. Using precisely positioned sediment core samples, our hydroacoustic‐geochemical approach can differentiate intra‐pockmark regimes that were formerly assigned to pockmarks of a different nature. We demonstrate that high‐frequency multibeam data, in particular the backscatter signals, can be used to detect shallow free gas in areas of enhanced groundwater advection in muddy sediments. Intriguingly, our data reveal relatively small (typically 〈15 m across) pockmarks within the much larger, previously mapped, pockmarks. The small pockmarks, which we refer to as “intra‐pockmarks”, have formed due to the localized ascent of gas and groundwater; they manifest themselves as a new type of ‘eyed’ pockmarks, revealed by their acoustic backscatter pattern. Our data suggest that, in organic‐rich muddy sediments, morphological lows combined with a strong multibeam backscatter signal can be indicative of free shallow gas and subsequent advective groundwater flow.
    Type: Article , PeerReviewed
    Format: text
    Format: text
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 2016-03-11
    Description: Evidence shows that factor VIII (FVIII) ectopically expressed in platelets (2bF8) is therapeutic in FVIII null mice even with anti-FVIII inhibitory antibodies (inhibitors). If current efforts to generate platelets in vitro succeed, genetically manipulated platelets containing FVIII may be used therapeutically in hemophilia A patients with inhibitors. One important concern is the immunogenicity of platelet-derived FVIII. To address this concern, we infused 2bF8 transgenic (2bF8 Tg ) platelets into naïve FVIII null mice weekly for 8 weeks. No anti-FVIII antibodies were detected in the infused animals during the study course. We then explored whether platelet-derived FVIII is immunogenic in FVIII null mice with inhibitors. The 2bF8 Tg platelets were transfused into rhF8-primed FVIII null mice, resulting in no augmentation of anti-FVIII antibodies. To investigate whether preconditioning affects the immune response, animals were sublethally irradiated and subsequently transfused with 2bF8 Tg platelets. No anti-FVIII antibodies were detected in the recipients after platelet infusions. Following further challenge with rhF8, the inhibitor titer in this group was significantly lower than in naïve FVIII null mice utilizing the same immunization protocol. Thus, our data demonstrate that infusion of platelets containing FVIII triggers neither primary nor memory anti-FVIII immune response in FVIII null mice and that sublethal irradiation plus 2bF8 Tg platelet infusion suppresses anti-FVIII immune response in FVIII null mice.
    Keywords: Thrombosis and Hemostasis
    Print ISSN: 0006-4971
    Electronic ISSN: 1528-0020
    Topics: Biology , Medicine
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Publication Date: 2014-01-17
    Description: Our previous studies have demonstrated that platelet FVIII (2bF8) gene therapy can improve hemostasis in hemophilia A mice, even in the presence of inhibitory antibodies, but none of our studies has targeted human cells. Here, we evaluated the feasibility for lentivirus (LV)-mediated human platelet gene therapy of hemophilia A. Human platelet FVIII expression was introduced by 2bF8LV-mediated transduction of human cord blood (hCB) CD34 + cells followed by xenotransplantation into immunocompromised NSG mice or NSG mice in an FVIII null background (NSGF8KO). Platelet FVIII was detected in all recipients that received 2bF8LV-transduced hCB cells as long as human platelet chimerism persisted. All NSGF8KO recipients (n = 7) that received 2bF8LV-transduced hCB cells survived tail clipping if animals had greater than 2% of platelets derived from 2bF8LV-transduced hCB cells, whereas 5 of 7 survived when human platelets were 0.3% to 2%. Whole blood clotting time analysis confirmed that hemostasis was improved in NSGF8KO mice that received 2bF8LV-transduced hCB cells. We demonstrate, for the first time, the feasibility of 2bF8LV gene delivery to human hematopoietic stem cells to introduce FVIII expression in human platelets and that human platelet–derived FVIII can improve hemostasis in hemophilia A.
    Keywords: Thrombosis and Hemostasis, Gene Therapy
    Print ISSN: 0006-4971
    Electronic ISSN: 1528-0020
    Topics: Biology , Medicine
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...